Is Mizhra an SSRI/ MAOI/opiate/ narcotic/ benzo/tricyclic antidepressant?
Nov 3, 2023
Is Mizhra an SSRI/ MAOI/opiate/ narcotic/ benzo/tricyclic antidepressant?
Mizhra classified as a tetracyclic antidepressant is a medication that is distinct from SSRI Selective Serotonin Reuptake Inhibitor MAOI Monoamine Oxidase Inhibitor opiate and narcotic drugs This antidepressant belongs to a class of medications specifically designed to alleviate symptoms of depression by affecting brain chemicals known as neurotransmitters Unlike SSRIs which primarily target the neurotransmitter serotonin Mizhra acts on multiple neurotransmitters including norepinephrine and dopamine to restore the chemical balance in the brain and improve mood By modulating the levels of these neurotransmitters Mizhra assists in relieving symptoms such as sadness loss of interest changes in appetite sleep disturbances and fatigue often associated with depression It is worth noting that Mizhra is not an MAOI a class of antidepressants that works by inhibiting the enzyme monoamine oxidase responsible for breaking down the neurotransmitters in the brain Additionally Mizhra should not be confused with opiate or narcotic medications as it does not possess the same analgesic properties or potential for addiction As with any medication it is important to follow the prescribed dosage and consult with a healthcare professional to determine the most appropriate treatment plan for depression or related disorders Mizhras unique mechanism of action and distinct classification among antidepressants make it a valuable option for individuals seeking relief from symptoms of depression
Medicines
For information purposes only. Consult a doctor before taking any medicines.
₹45₹50
₹52₹58
₹71₹79
₹56₹62
₹70₹78
₹49₹54